The Australian Technical Advisory Group on Immunisation (ATAGI) has released recommendations on the use of COVID-19 vaccines in all young adolescents in Australia.

The advice recommends children aged 12-15 be vaccinated against 新冠肺炎 using Comirnaty (Pfizer).

A summary of ATAGI recommendations includes:

  • Vaccination against COVID-19 is recommended for all individuals from 12 years of age, extending the current recommendation for those aged 16 years and older.
  • A two-dose schedule using Comirnaty (Pfizer), the only vaccine currently registered for use in Australia in this age group, is recommended.
  • Recommendations on the use of Spikevax (Moderna) for adolescents will be finalised following the decision on provisional registration of Spikevax (Moderna) in this age group.

To read the statement in full, please click the link below:
ATAGI recommendations on the use of COVID-19 vaccines in all young adolescents in Australia

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个